Patents by Inventor David C Fry

David C Fry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Neuropeptide-2 receptor (Y-2R) agonists and uses thereof
    Patent number: 7410949
    Abstract: Provided herein are neuropeptide-2 receptor agonists of the formula (I): Y—R1—R2—X—R3—R4—R5—R6—R7—R8—R9—R10—R11—R12—R13—R14—NH2, ??(I) as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity.
    Type: Grant
    Filed: January 10, 2006
    Date of Patent: August 12, 2008
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Waleed Danho, George Ehrlich, David C Fry, Wajiha Khan, Joseph Swistok
  • Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
    Patent number: 5084442
    Abstract: Linear and cyclic Growth Hormone Releasing Factor Analogs and a method for stimulating the release of Growth Hormone in subjects by administering to the subject an effective amount of the compounds of the invention.
    Type: Grant
    Filed: September 6, 1988
    Date of Patent: January 28, 1992
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Arthur M. Felix, David C. Fry, Edgar P. Heimer, Vincent S. Madison